Long-term outcomes of thrombectomy for acute ischaemic stroke by occluded artery and stroke aetiology: a PRAGUE-16 substudy.
Journal
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
ISSN: 1969-6213
Titre abrégé: EuroIntervention
Pays: France
ID NLM: 101251040
Informations de publication
Date de publication:
11 Jun 2021
11 Jun 2021
Historique:
pubmed:
19
5
2020
medline:
16
6
2021
entrez:
19
5
2020
Statut:
epublish
Résumé
Thrombectomy is an effective treatment for acute ischaemic stroke (AIS). The aim of this study was to compare clinical outcomes with intracranial artery occlusion site among AIS patients treated in the setting of a cardiology cath lab. This was a single-centre, prospective registry of 214 consecutive patients with AIS enrolled between 2012 and 2018. All thrombectomy procedures were performed in a cardiology cath lab with stent retrievers or aspiration systems. The functional outcome was assessed by the modified Rankin Scale (mRS) after three months. Ninety-three patients (44%) had middle cerebral artery (MCA) occlusion, 28 patients (13%) had proximal internal carotid artery (ICA) occlusion, 27 patients (13%) had tandem (ICA+MCA) occlusion, 39 patients (18%) had terminal ICA (T-type) occlusion, and 26 patients (12%) had vertebrobasilar (VB) stroke. Favourable clinical outcome (mRS ≤2) was reached in 58% of MCA occlusions and in 56% of isolated ICA occlusions, but in only 31% of T-type occlusions and in 27% of VB stroke. Poor clinical outcome in T-type occlusions and VB strokes was influenced by the lower recanalisation success (mTICI 2b-3 flow) rates: 56% (T-type) and 50% (VB) compared to 82% in MCA occlusions, 89% in isolated ICA occlusions and 96% in tandem occlusions. Catheter-based thrombectomy achieved significantly better clinical results in patients with isolated MCA occlusion, isolated ICA occlusions or tight stenosis and tandem occlusions compared to patients with T-type occlusion and posterior strokes. Visual summary. Endovascular intervention of isolated MCA or ICA occlusions provides greatest clinical benefit, while interventions in posterior circulation have lower chance for clinical success.
Sections du résumé
BACKGROUND
BACKGROUND
Thrombectomy is an effective treatment for acute ischaemic stroke (AIS).
AIMS
OBJECTIVE
The aim of this study was to compare clinical outcomes with intracranial artery occlusion site among AIS patients treated in the setting of a cardiology cath lab.
METHODS
METHODS
This was a single-centre, prospective registry of 214 consecutive patients with AIS enrolled between 2012 and 2018. All thrombectomy procedures were performed in a cardiology cath lab with stent retrievers or aspiration systems. The functional outcome was assessed by the modified Rankin Scale (mRS) after three months.
RESULTS
RESULTS
Ninety-three patients (44%) had middle cerebral artery (MCA) occlusion, 28 patients (13%) had proximal internal carotid artery (ICA) occlusion, 27 patients (13%) had tandem (ICA+MCA) occlusion, 39 patients (18%) had terminal ICA (T-type) occlusion, and 26 patients (12%) had vertebrobasilar (VB) stroke. Favourable clinical outcome (mRS ≤2) was reached in 58% of MCA occlusions and in 56% of isolated ICA occlusions, but in only 31% of T-type occlusions and in 27% of VB stroke. Poor clinical outcome in T-type occlusions and VB strokes was influenced by the lower recanalisation success (mTICI 2b-3 flow) rates: 56% (T-type) and 50% (VB) compared to 82% in MCA occlusions, 89% in isolated ICA occlusions and 96% in tandem occlusions.
CONCLUSIONS
CONCLUSIONS
Catheter-based thrombectomy achieved significantly better clinical results in patients with isolated MCA occlusion, isolated ICA occlusions or tight stenosis and tandem occlusions compared to patients with T-type occlusion and posterior strokes. Visual summary. Endovascular intervention of isolated MCA or ICA occlusions provides greatest clinical benefit, while interventions in posterior circulation have lower chance for clinical success.
Identifiants
pubmed: 32420880
pii: EIJ-D-19-00997
doi: 10.4244/EIJ-D-19-00997
pmc: PMC9725002
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e169-e177Références
JACC Cardiovasc Interv. 2019 Sep 9;12(17):1703-1710
pubmed: 31488297
J Neurointerv Surg. 2019 Jun;11(6):535-538
pubmed: 31152058
Lancet Neurol. 2003 Feb;2(2):89-98
pubmed: 12849265
Stroke. 2004 Aug;35(8):1903-7
pubmed: 15178819
Lancet. 2005 Nov 19;366(9499):1773-83
pubmed: 16298214
EuroIntervention. 2017 May 15;13(1):131-136
pubmed: 28242586
Circulation. 2016 Jan 26;133(4):e38-360
pubmed: 26673558
Cerebrovasc Dis. 2011;32(4):370-82
pubmed: 21921601
J Neurointerv Surg. 2015 Dec;7(12):868-74
pubmed: 25271064
J Neurointerv Surg. 2016 Oct;8(10):989-91
pubmed: 26888954
Lancet Neurol. 2011 Nov;10(11):1002-14
pubmed: 22014435
Scand Cardiovasc J. 2014 Dec;48(6):335-8
pubmed: 25375813
J Neurointerv Surg. 2019 Mar;11(3):241-245
pubmed: 30415226
J Am Heart Assoc. 2018 Dec 18;7(24):e010867
pubmed: 30561262
Trends Cardiovasc Med. 2017 Jan;27(1):59-66
pubmed: 27471112
J Am Coll Cardiol. 2015 Jul 28;66(4):487-8
pubmed: 26205603
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Cardiovasc J Afr. 2008 Jul-Aug;19(4):204-7
pubmed: 18776966
Stroke. 2009 Dec;40(12):3777-83
pubmed: 19875740
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
EuroIntervention. 2014 Nov;10(7):876-83
pubmed: 25415153
J Neurointerv Surg. 2016 Mar;8(3):224-9
pubmed: 25564538
Am J Cardiol. 1998 Oct 16;82(8A):2N-9N
pubmed: 9809895
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852